Endoscopic sleeve gastroplasty vs lifestyle modification for weight loss: A real-world cost-effectiveness study

Figure 2 One-way sensitivity analysis. The base-case value for the annual cost of the new intervention is 5904 dollars and is represented by the y axis. In one way sensitivity analysis (OWSA), this varies this cost from 4603 dollars to 8098 dollars and is comfortably below the commonly cited United States willingness-to-pay threshold of 100000 dollars per quality adjusted life year. Parameters included in the OWSA were age, sex, obesity class, mortality risk, intervention costs, and annual obesity-related direct healthcare costs. Model scenarios included in the OWSA were variable time horizons (5-year, 10-year, and lifetime) and annual discount rate for costs and health effects (0%, 3%, and 6%). ESG: Endoscopic sleeve gastroplasty; HR: Hazard ratio.